Jose McFaline-Figueroa MD, PhDPhysician, Center for Neuro-Oncology, Dana-Faber Cancer Institute; Instructor in Neurology, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Jose “Ricky” McFaline-Figueroa, MD, PhD is a physician at the Center for Neuro-Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, and an Instructor in Neurology at Harvard Medical School in Boston, MA. He received his BS in Chemistry from the University of Puerto Rico at Mayaguez, PR, and his MD and PhD at Columbia University, New York, NY. He completed his internship in internal medicine at Massachusetts General Hospital and his residency at the Harvard BWH-MGH Neurology Residency Program at Brigham and Women’s Hospital and Massachusetts General Hospital, Boston, MA. He completed his fellowship in the combined Massachusetts General Hospital/Dana-Farber Cancer Institute Neuro-Oncology Fellowship Program.
Dr. McFaline-Figueroa’s research focuses on glioblastoma, in particular, the use of combinatorial therapies to enhance response to immunotherapy in this disease. He is a recipient of the Paul Calabresi Career Development Award for Clinical Oncology and a scholar of the Massachusetts General Hospital Training Program in Central Nervous System Tumors.
Recent Contributions to PracticeUpdate:
- Management of Asymptomatic Brain Lesion
- CCNU/temozolomide vs Temozolomide Alone in MGMT-Methylated Glioblastoma
- Interpreting Brain Pathology Reports in Cases of True Progression vs Pseudo-Progression in Glioblastoma After Irradiation
- Radiosensitizers in Radiation Treatment of Gliomas
- Radiotherapy After Resection of Intracranial Metastases
- Tumor Treating Fields and Radiosurgery for Brain Metastases Related to NSCLC
- Quality of Life Following Re-Irradiation for Recurrent High Grade Glioma
- Ipilimumab and Nivolumab for Newly Diagnosed GBM
- Immune Checkpoint-blockade Associated Axonal Polyneuropathy
- Adjuvant Therapy for WHO Grade II Oligodendroglioma s/p Biopsy